Insider filing · MDGL
William John Sibold
President and CEO
profile →
Madrigal Pharmaceuticals, Inc.
MDGL · Healthcare · 59 filings in 24 months
ticker →
William John Sibold sold $531K of Madrigal Pharmaceuticals (MDGL)
Executed Jan 24 2025, disclosed Jan 27 2025, 3 days later.
Value, as filed
$531K
1,584 sh × $335.24
Executed
Jan 24 2025
the trade date, as filed
Disclosed
Jan 27 2025
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
WSWilliam John Sibold (President and CEO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Madrigal Pharmaceuticals, Inc. (MDGL). The largest single filing was $5.8M of MDGL (10,846 sh across 18 lots, as filed), executed Sep 9.
The name
MDGLHealthcare · Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by William John Sibold in MDGL
MDGLSALE
Madrigal Pharmaceuticals, Inc.
$5.8M10,846 sh across 18 lots
Exec Sep 9
Filed Sep 11 · 4:57 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $1.1M
2,049 sh across 5 lots
Exec Jul 20
Filed Jul 20 · 9:16 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $718K
1,663 sh × $431.94
Exec Mar 6
Filed Mar 6 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $777K
1,577 sh × $492.42
Exec Jan 26
Filed Jan 26 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $1.4M
2,400 sh × $575.34
Exec Dec 4 2025
Filed Dec 4 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $3.2M
7,279 sh × $445.63
Exec Sep 9 2025
Filed Sep 9 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $3.0M
7,616 sh across 2 lots
Exec Aug 21 2025
Filed Aug 21 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $1.6M
6,363 sh × $243.83
Exec Sep 9 2024
Filed Sep 11 2024 · 5:30 PM ET